Lori A. Ehrlich
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Oncology top 5%
- Bone health and treatments
- Peptidase Inhibition and Analysis
- Chemokine receptors and signaling
Papers in
- Hematology 14
- Multiple Myeloma Research and Treatments 7
- Chronic Myeloid Leukemia Treatments 5
-
- Acute Lymphoblastic Leukemia research 5
- Co-authors
- G. David Roodman (6 shared papers)Sun Jin Choi (5 shared papers)Diane F. Jelinek (3 shared papers)Natalie S. Callander (2 shared papers)Junwon Lee (3 shared papers)Ho Yeon Chung (2 shared papers)Irene M. Ghobrial (2 shared papers)G. David Roodman (2 shared papers)
- Journals
- Clinical Cancer Research (5 papers)Blood (3 papers)Cell Cycle (2 papers)Journal of Clinical Oncology (2 papers)Hematology/Oncology Clinics of North America (1 paper)
- Partner nations
- United StatesSlovakiaSouth Korea
In The Last Decade
Lori A. Ehrlich
20 papers receiving 695 citations
Peers
Comparison fields: 5 of 69
- Hematology 409
- Oncology 465
- Orthopedics and Sports Medicine 49
- Immunology and Allergy 30
- Genetics 48
Countries citing papers authored by Lori A. Ehrlich
This map shows the geographic impact of Lori A. Ehrlich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori A. Ehrlich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori A. Ehrlich more than expected).
Fields of papers citing papers by Lori A. Ehrlich
This network shows the impact of papers produced by Lori A. Ehrlich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori A. Ehrlich. The network helps show where Lori A. Ehrlich may publish in the future.
Co-authors
The 25 scholars most cited alongside Lori A. Ehrlich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 175 | |
| 2 | 2005 | 147 | |
| 3 | 2005 | 119 | |
| 4 | 2005 | 75 | |
| 5 | 2006 | 75 | |
| 6 | 2007 | 37 | |
| 7 | 2016 | 17 | |
| 8 | 2020 | 14 | |
| 9 | 2017 | 13 | |
| 10 | 2014 | 8 | |
| 11 | 2023 | 5 | |
| 12 | 2017 | 5 | |
| 13 | 2024 | 4 | |
| 14 | 2023 | 3 | |
| 15 | 2015 | 3 | |
| 16 | 2024 | 2 | |
| 17 | 2003 | 2 | |
| 18 | 2022 | 1 | |
| 19 | 2004 | 1 | |
| 20 | 2006 | 1 |
About Lori A. Ehrlich
Lori A. Ehrlich is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Molecular Biology, Genetics and Oncology, having authored 20 papers that have together received 707 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (7 papers), Chronic Lymphocytic Leukemia Research (5 papers), Acute Lymphoblastic Leukemia research (5 papers), Chronic Myeloid Leukemia Treatments (5 papers), Bone Metabolism and Diseases (4 papers), Cell Adhesion Molecules Research (3 papers), Bone health and treatments (3 papers) and Chemokine receptors and signaling (2 papers). The work is most often cited by research in Hematology (409 citations), Oncology (465 citations), Orthopedics and Sports Medicine (49 citations), Immunology and Allergy (30 citations) and Genetics (48 citations). Lori A. Ehrlich has collaborated with scholars based in United States, Slovakia and South Korea. Frequent co-authors include G. David Roodman, Sun Jin Choi, Diane F. Jelinek, Natalie S. Callander, Junwon Lee, Ho Yeon Chung, Irene M. Ghobrial, G. David Roodman, Suzanne Lentzsch and Simona Colla. Their work appears in journals such as Clinical Cancer Research, Blood, Cell Cycle, Journal of Clinical Oncology and Hematology/Oncology Clinics of North America.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.